Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $6.58 Million - $8.66 Million
163,420 Added 257.6%
226,859 $9.42 Million
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $7.84 Million - $8.89 Million
-163,420 Reduced 72.04%
63,439 $3.44 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $12.2 Million - $14.5 Million
-251,230 Reduced 52.55%
226,859 $11.6 Million
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $1.46 Million - $1.64 Million
-25,263 Reduced 5.02%
478,089 $27.7 Million
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $3.1 Million - $3.44 Million
-48,656 Reduced 8.81%
503,352 $32.2 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $8.63 Million - $9.79 Million
131,310 Added 31.21%
552,008 $38.3 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $2.64 Million - $3.13 Million
38,589 Added 10.1%
420,698 $30.3 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $19,393 - $11.5 Million
149,183 Added 64.05%
382,109 $27.4 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $2.94 Million - $3.23 Million
40,432 Added 21.0%
232,926 $17.9 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $3.76 Million - $4.51 Million
61,208 Added 46.62%
192,494 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $5.54 Million - $6.45 Million
-103,240 Reduced 44.02%
131,286 $8.19 Million
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $1.54 Million - $1.8 Million
-26,039 Reduced 9.99%
234,526 $13.9 Million
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $27.3 Million - $29.7 Million
-440,577 Reduced 62.84%
260,565 $17.3 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $12.3 Million - $13.8 Million
-206,963 Reduced 22.79%
701,142 $44.3 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $44,402 - $50,315
769 Added 0.08%
908,105 $56.3 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $3.17 Million - $3.51 Million
-55,168 Reduced 5.73%
907,336 $54.7 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $49.9 Million - $58.3 Million
909,467 Added 1714.78%
962,504 $56.6 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $2.46 Million - $3.58 Million
53,037 New
53,037 $2.95 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $19 Million - $22.7 Million
-422,027 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $1.89 Million - $2.46 Million
-38,839 Reduced 8.43%
422,027 $21.9 Million
Q3 2018

Nov 05, 2018

SELL
$55.19 - $62.25 $12.7 Million - $14.3 Million
-230,132 Reduced 33.3%
460,866 $28.6 Million
Q2 2018

Jul 24, 2018

BUY
$50.53 - $62.98 $34.9 Million - $43.5 Million
690,998 New
690,998 $38.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Unigestion Holding Sa Portfolio

Follow Unigestion Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Unigestion Holding Sa with notifications on news.